The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 21.16

Cancer of the Ovary (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2010-2014
Females by Race

Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 24,756 91.6% 20,308 92.2% 2,063 87.5% 2,109 91.1% 118 86.1% 3,178 87.5%
Epidermoid carcinomad (8051-8131) 172 0.6% 130 0.6% 17 0.7% 25 1.1% - - 32 0.9%
Adenocarcinomae 22,797 84.3% 18,817 85.4% 1,793 76.1% 1,937 83.7% 109 79.6% 2,881 79.3%
Adenocarcinoma, NOS (8140) 2,891 10.7% 2,353 10.7% 350 14.8% 159 6.9% - - 353 9.7%
Papillary adenocarcinoma, NOS (8050,8260) 266 1.0% 215 1.0% 28 1.2% 17 0.7% - - 33 0.9%
Clear cell adenocarcinoma (8310,9110) 1,478 5.5% 1,108 5.0% 76 3.2% 275 11.9% - - 166 4.6%
Endometrioid carcinoma (8380-8383,8570) 2,668 9.9% 2,169 9.8% 145 6.2% 324 14.0% - - 415 11.4%
Cystadenocarcinoma, NOS (8440,8450) 61 0.2% 48 0.2% - - - - - - - -
Serous cystadenocarcinoma (8441) 7,751 28.7% 6,517 29.6% 596 25.3% 550 23.8% 41 29.9% 858 23.6%
Papillary serous cystadenocarcinoma (8460-8462) 4,807 17.8% 4,068 18.5% 391 16.6% 302 13.0% 21 15.3% 612 16.9%
Mucinous cystadenocarcinoma (8470-8473) 328 1.2% 257 1.2% 21 0.9% 46 2.0% - - 45 1.2%
Mucinous adenocarcinoma (8480,8482) 1,082 4.0% 861 3.9% 88 3.7% 118 5.1% - - 161 4.4%
Mucin-producing adenocarcinoma(8481) 26 0.1% 19 0.1% - - - - - - - -
Other adenocarcinomaf 1,439 5.3% 1,202 5.5% 87 3.7% 138 6.0% - - 224 6.2%
Other specific carcinomasg 670 2.5% 464 2.1% 143 6.1% 50 2.2% - - 111 3.1%
Stromal cell tumor (8620-8631,8650) 487 1.8% 324 1.5% 119 5.0% 33 1.4% - - 83 2.3%
Otherh 183 0.7% 140 0.6% 24 1.0% 17 0.7% - - 28 0.8%
Unspecified, Carcinoma, NOS (8010,8020-8022) 1,117 4.1% 897 4.1% 110 4.7% 97 4.2% - - 154 4.2%
Sarcoma and other soft tissue tumors (8680-8713,8800-8921, 8990-8991,9040-9044, 9120-9136,9141-9340, 9540-9582) 84 0.3% 60 0.3% 16 0.7% - - - - 21 0.6%
Other specific types (8240-8246,8720-8790, 8930-8936,8950-8983, 9000-9030,9060-9105, 9350-9364,9380-9513, 9530-9539) 1,890 7.0% 1,439 6.5% 231 9.8% 172 7.4% - - 392 10.8%
Mullerian mixed tumor (8950-8951,8980) 892 3.3% 739 3.4% 85 3.6% 53 2.3% - - 109 3.0%
Teratoma, malignant (9080-9085,9102) 404 1.5% 264 1.2% 67 2.8% 54 2.3% - - 145 4.0%
Other 594 2.2% 436 2.0% 79 3.4% 65 2.8% - - 138 3.8%
Unspecified (8000-8005) 301 1.1% 218 1.0% 47 2.0% 28 1.2% - - 40 1.1%
Totald 27,031 100.0% 22,025 100.0% 2,357 100.0% 2,315 100.0% 137 100.0% 3,631 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8050,8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941,9110.

f Other adenocarcinoma includes histologies 8141-8147,8160-8162,8180-8221,8250-8259,8261-8309,8311-8379,8384-8439,8442-8449, 8451-8459,8463-8469,8474-8479,8483-8507,8514,8520-8551,8560,8571-8574,8576,8940-8941.

g Other specific carcinomas includes histologies 8011-8015,8030-8046,8150-8155,8170-8175,8230-8231,8247-8249,8508,8510-8513, 8561-8562,8575,8580-8671.

h Other subgroup of other specific carcinomas includes histologies 8011-8015,8030-8046,8150-8155,8170-8175,8230-8231,8247-8249,8508,8510-8513,8561-8562,8575,8580-8619,8632-8649,8651-8671.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.